Publicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (10)

2022

  1. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

    Cellular Immunology, Vol. 382

  2. Hyperthermic Intraperitoneal Chemotherapy and Recirculation with CO2: A Safe Technique

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. A reliable and standardizable differential PCR and qPCR methodology assesses HER2 gene amplification in gastric cancer

    Biology, Vol. 10, Núm. 6

  2. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

  3. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 2, pp. 774-783

2020

  1. Defects at the posttranscriptional level account for the low TCRζ chain expression detected in gastric cancer independently of caspase-3 activity

    Journal of Immunology Research, Vol. 2020

2019

  1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2615-2621

2013

  1. Perioperative chemotherapy for resectable gastroesophageal cancer: A single-center experience

    European Journal of Surgical Oncology, Vol. 39, Núm. 8, pp. 814-822

2004

  1. Prolapso rectal completo en el contexto de las enfermedades del suelo pélvico. Nuestra experiencia en la resección por la vía perineal

    Cirugia Espanola, Vol. 75, Núm. 6, pp. 344-349

2000

  1. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy

    Anticancer Research, Vol. 20, Núm. 5 C, pp. 3929-3933